crack pressur yet
omnicom result ahead organ ebita margin
consensu ep beat plu financi pointer given manag
lead us increas ep key question face investor whether
agre manag bullish stori organ better thank
net account win benefit dispos client spend increas
margin thank restructur benefit restructur cost paid capit gain
year signific disposit altern deterior
underli busi impli account win need stand still restructur
prevent margin declin manag decid sell agenc
busi shore organ lean toward altern scenario
industri peopl agre creativ one pressur omnicom
first foremost creative-bas hold underweight
view quit binari acknowledg lack visibl increas price
target higher forecast
result expect revenu decreas
barclay thank organ vs vs ebita
increas forecast includ
one-off underli ebita increas ahead dilut ep
increas ahead adjust except dilut ep
increas consensu
ep upgrad model chang result ep upgrad
bloomberg consensu establish pre result
quarterli annual ep usd
consensu number thomson reuter receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
research report prepar whole part equiti research analyst
base outsid us registered/qualifi research analyst finra
rais usd
return equiti ttm
link barclay live interact chart
margin return data
flow balanc sheet mn
chang work capit
flow oper
equival
short long-term debt
valuat leverag metric
underweight investor alreadi
bearish agenc still see downsid risk
bullish macro/advertis environ
could add upsid price target
less bullish macro/advertis environ
could lower price target
point result earn call
result ahead revenu decreas forecast
thank organ vs vs ebita increas
forecast includ one-off
underli ebita increas forecast dilut ep
increas forecast adjust except
dilut ep increas forecast
consensu
ep upgrad make sever chang model input actual
increas organ lower fx increas increas ebita margin overal
chang result ep upgrad
 bloomberg consensu
establish pre result
wpp omnicom also use capit gain restructur without impact
omnicom disclos oper profit includ capit gain asset
dispos restructur highlight let
peopl go cost salari would hire peopl differ
profil benefit restructur plan would off-set dilut impact
dispos theoret could seen posit painless restructur
wpp twice margin increas top line remain
pressur expect similar outcom omnicom restructur
posit busi continu grow otherwis expect benefit
cautious optimist organ ceo john wren state cautious
optimist especi go optim base primarili three
thing one lost larg client headwind go
year pretti handsom win start kick first
quarter next year three client certainli look cut
back look invest busi logic underli
busi deterior ford add organ dispos
asset gsk loss howev neg final ceo john wren also
mention signific account review announc novemb
impact disposit organ result cfo phil angelastro state
sold busi sold whole organ growth would
less higher result slide show organ
would higher dispos done begin
quarter investor rush conclud omnicom organ
faster compani deliv would
remind omnicom sold busi worth revenu
busi also somewhat struggl organ
lower
get high multipl disposit omnicom cash flow show
proce dispos base cfo phil angelastro revenu guidanc
busi would revenu margin
close group averag inde cfo phil angelastro said call
basket smaller disposit probabl lower margin averag
bigger busi probabl line bit higher base three element
dispos price revenu margin calcul omnicom sold
busi ev/ebitda ev/ebita remind last year calcul
omnicom sold non-cor busi ev/ebita inde base
guidanc disposit impact calcul busi sold
gener revenu month base posit
margin contribut also calcul would gener
ebita margin omnicom gener proce
invest first nine month purchas sale broken
assum spent last year omnicom would
sold busi equat ev/ebita multipl
omnicom incred shrink act come end ask whether
would disposit revenu ie omnicom
end sold ceo john wren state look portfolio
noth burn desir dispos compani
streamlin happi perform said alway
except pop time time get fair price compani
longer fit strateg sell compani believ believ
manag key question face investor believ doubl
answer omnicom inde deliv acceler organ next year major dispos
like stop howev omnicom struggl organ manag like
sell asset fix organ view
decoupl growth us partli blame programmat taken in-
hous ask organ longer track growth us ceo
john wren state structur chang occur
busi especi programmat done us past fairli
high revenu associ client decid take in-hous still
make roughli amount money look profit ebit
revenu lower
focu geographi europ asia pacif region anoth quarter strong
perform organ respect within europ franc itali
spain continu perform well germani under-perform overal us
repres omnicom revenu grew organ adjust
disposit
media still fine creativ still mix improv cfo phil angelastro state media
pace organ growth global nation advertis agenc
continu experi mix perform see improv
compar earlier quarter includ us
lower organ better drag
line drag sinc accuen growth either roughli
flat neg clear client opt transpar approach
accuen longer growth engin omnicom
financi guidanc cfo phil angelastro state fx
neg impact expect neg impact
neg impact tax rate around
make sever chang model
increas organ
lower fx
increas
increas ebita margin
overal chang result ep upgrad
 bloomberg
consensu establish pre result
figur omnicom chang forecast
focu programmat growth
omnicom start disclos accuen growth programmat buy platform
result call includ figur
figur accuen growth slow
sinc accuen growth either roughli flat neg result
manag highlight chang client prefer toward tradit
programmat busi away perform base offer accuen
manag expect shift continu go forward clear client
opt transpir approach
result ahead expect
omnicom report result ahead expect revenu decreas
barclay forecast revenu grew organ fx
contribut contribut ebita increas
ahead barclay forecast includ one-off restructur cost
underli ebita increas ahead barclay forecast
geographi organ growth versu unit state
europ asia pacif latin america north america declin
unit kingdom declin middl east africa declin
dilut ep increas barclay forecast adjust
except dilut ep increas barclay
omnicom also announc dividend line forecast
growth us contribut term organ barclay
focu organ growth rate
figur show omnicom quarterli organ growth profil quarterli forecast
fy result call manag guid organ revenu
growth current model previou forecast
maintain estim forecast adjust accuen
decemb year-end us amortis tax tax particip number dilut ep ex merger barclay
compani data barclay research estim pleas note histor organ growth exclud accuen
adjust omnicom histor organ growth
exclud accuen organ make figur compar peer group
accuen declin continu weak trend manag
explain slowdown accuen due client shift prefer
agent type relationship away less transpar bundl approach
omnicom act princip remind accuen growth contribut organ
forecast report basi includ accuen
figur show organ growth rate omnicom ex accuen peer hava
vivendi publici wpp yet report number reflect barclay estim
interpubl partner dentsu cover barclay
compani data barclay research average repres weight average revenu hava wpp publici reflect barclay estim interpubl
dentsu partner cover barclay omnicom organ exclud accuen organ growth sinc
impact
figur show price-to-earnings ev/ebitda ev/sal agenc base headlin
ep estim ex amortis intang omnicom current trade
price-to-earnings premium global peer averag respect
term ev/ebitda omnicom trade
premium peer respect
note ow overweight ew equal weight uw underweight full disclosur cover compani includ detail company-specif valuat
methodolog risk pleas refer http //publicresearch barcap com sourc datastream barclay research except datastream consensu share price
close octob
trade price-to-earnings accord datastream report ep consensu pre result
omnicom current averag trade sinc
averag sinc
rel basi use datastream report ep consensu omnicom current
trade discount us market averag sinc
chart plot omnicom organ growth versu share price forward pe
share price rel sinc omnicom pe shown good direct correl
datastream barclay research organ growth forecast
decemb year-end us asia latin africa servic gener amortis net tax tax particip number dilut dilut ep pre intang barclay
decemb year-end us servic gener amortis net tax tax particip number dilut dilut barclay
decemb year-end us incom amort intang non work oper properti plant net invest invest payment buy-back non control financ financ exchang rate chang year-end us current properti plant invest intang total sharehold equiti inc current long term total liabil sharehold net barclay
julien roch herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
research analyst employ outsid us affili barclay capit inc registered/qualifi research analyst finra
non-u research analyst may associ person barclay capit inc finra member therefor may subject
finra rule restrict commun subject compani public appear trade secur held research analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
price sourc thomson reuter last avail close price relev trade market unless anoth time sourc
